SWX:NOVNPharmaceuticals
Novartis (SWX:NOVN) Pays $125 Million For Brain Drug Delivery Rights
Novartis (SWX:NOVN) agreed to acquire full global rights to Sironax's brain delivery platform for $125 million upfront.
The platform is designed to help transport therapies across the blood brain barrier for neurological and rare brain disorders.
Sironax keeps certain rights to develop its own pipeline on the technology while Novartis gains broad access to the core platform.
Novartis securing Sironax's brain delivery platform matters, but investors should weigh it alongside other factors for...